Skip to main content

Soluble Adamantyl Glycosphingolipid Analogs as Probes of Glycosphingolipid Function

  • Protocol
Glycobiology Protocols

Abstract

Despite the extensive structural characterization of glycosphingolipids (GSLs), their functions in cell physiology and pathobiology remain elusive. This is largely owing to the fact that they are difficult to handle, being insoluble in aqueous media, and that no one gene alone determines their synthesis. The heterogeneity of the lipid moiety provides a further confounding factor. GSLs are central components within lipid rafts, which are major foci for transmembrane signaling and interactions between eukaryotic cells and microbial pathogens. GSL receptor function often requires the lipid moiety, and lipid-free sugar analogs are ineffective inhibitors. In order to overcome some of these problems, we have synthesized adamantyl GSL analogs which, in part, mimic GSL membrane receptor function in solution. These compounds are made by replacing the endogenous fatty acid with an adamantan frame. This rigid hydrophobic structure surprisingly increases the water solubility of the conjugate and retains receptor function. These GSL mimics provide probes to study GSL receptor function within cells. They compete with native GSLs for ligand binding and are taken up by cells to potentially alter GSL-mediated interaction. We are focused on two derivatives, adamantyl globotriaosyl ceramide and adamantyl sulfogalactosyl ceramide, and have used these analogs to probe GSL function in microbial pathology and hsp70 function. This chapter describes the syntheses and uses of these mimics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Golub, T., Wacha, S., and Caroni, P. (2004) Spatial and temporal control of signaling through lipid rafts. Curr. Opin. Neurobiol. 14, 542–550.

    Article  CAS  PubMed  Google Scholar 

  2. van der Goot, F. G. and Harder, T. (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin. Immunol. 13, 89–97.

    Article  PubMed  Google Scholar 

  3. Lingwood, C. A. (1996) Aglycone modulation of glycolipid receptor function. Glycoconj. J. 13, 495–503.

    Article  CAS  PubMed  Google Scholar 

  4. Lingwood, C., Mylvaganam, M., Minhas, F., Binnington, B., Branch, D., and Pomes, R. (2005) The sulfogalactose moiety of sulfoglycosphingolipids serves as a mimic of tyrosine phosphate in many recognition processes: prediction and demonstration of SH2 domain/sulfogalactose binding. J. Biol. Chem. 280, 12,542–12,547.

    Article  CAS  PubMed  Google Scholar 

  5. Lingwood, C. A. (2003) Shiga Toxin Receptor Glycolipid Binding: Pathology and Utility. Methods in Molecular Medicine, vol. 73, Shigatoxin-Producing Escherichia Coli: Methods and Protocols (Philpott, D. and Ebel, F., eds.), Humana Press, Totowa, NJ, pp. 165–186.

    Google Scholar 

  6. Lingwood, C. A. (1999) Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. Biochim. Biophys. Acta. 1455, 375–386.

    CAS  PubMed  Google Scholar 

  7. Boyd, B., Zhiuyan, Z., Magnusson, G., and Lingwood, C. A. (1994) Lipid modulation of glycolipid receptor function: Presentation of galactose α1-4 galactose disaccharide for Verotoxin binding in natural and synthetic glycolipids. Eur. J. Biochem. 223, 873–878.

    Article  CAS  PubMed  Google Scholar 

  8. Mamelak, D. and Lingwood, C. (1997) Expression and sulfogalactolipid binding of the recombinant testis-specific cognate heat shock protein 70. Glycoconj. J. 14, 715–722.

    Article  CAS  PubMed  Google Scholar 

  9. Mylvaganam, M., Binnington, B., Hansen, H., Magnusson, G., and Lingwood, C. (2002) Interaction of verotoxin 1 B subunit with globotriaosyl ceramide analogues: Aminosubstituted (aminodeoxy) adamantylGb3Cer provides insight into the nature of the Gb3Cer binding sites. Biochem. J. 368, 769–776.

    Article  CAS  PubMed  Google Scholar 

  10. Nyholm, P. G., Magnusson, G., Zheng, Z., Norel, R., Binnington-Boyd, B., and Lingwood, C. A. (1996) Two distinct binding sites for globotriaosyl ceramide on verotoxins: molecular modelling and confirmation by analogue studies and a new glycolipid receptor for all verotoxins. Chem. Biol. 3, 263–275.

    Article  CAS  PubMed  Google Scholar 

  11. Mamelak, D., Mylvaganam, M., Tanahashi, E., et al. (2001) The aglycone of sulfogalactolipids can alter the sulfate ester substitution position required for hsc70 recognition. Carbohydr. Res. 335, 91–100.

    Article  CAS  PubMed  Google Scholar 

  12. Kiarash, A., Boyd, B., and Lingwood, C. A. (1994) Glycosphingolipid receptor function is modified by fatty acid content: Verotoxin 1 and Verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269, 11,138–11,146.

    CAS  PubMed  Google Scholar 

  13. Nutikka, A. and Lingwood, C. (2004) Generation of receptor active, globotriaosyl ceramide/cholesterol lipid ‘rafts’ in vitro: a new assay to define factors affecting glycosphingolipid receptor activity. Glycoconj. J. 20, 22–38.

    Google Scholar 

  14. Mylvaganam, M. and Lingwood, C. A. (2003) In Carbohydrate-based Drug Discovery, Vol. 2 (Wong, C.-H., ed.), Wiley-VCH, Weinheim, Germany, pp. 761–780.

    Google Scholar 

  15. Lingwood, C. A. and Mylvaganam, M. (2003) In Methods in Enzymology, vol. 363 (Lee, Y. C. and Lee, R. T., eds.), Academic Press, San Diego, pp. 264–284.

    Google Scholar 

  16. Strömberg, N., Nyholm, P.-G., Pascher, I., and Normark, S. (1991) Saccharide orientation at the cell surface affects glycolipid receptor function. Proc. Natl. Acad. Sci. USA 88, 9340–9344.

    Article  PubMed  Google Scholar 

  17. Gaus, K., Gratton, E., Kable, E. P., et al. (2003) Visualizing lipid structure and raft domains in living cells with two-photon microscopy. Proc. Natl. Acad. Sci. USA 100, 15,554–15,559.

    Article  CAS  PubMed  Google Scholar 

  18. Kitov, P. I., Sadowska, J. M., Mulvey, G., et al. (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403, 669–672.

    Article  CAS  PubMed  Google Scholar 

  19. Nishikawa, K., Matsuoka, K., Kita, E., et al. (2002) A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc. Natl. Acad. Sci. USA 99, 7669–7674.

    Article  CAS  PubMed  Google Scholar 

  20. Watanabe, M., Matsuoka, K., Kita, E., et al. (2004) Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. J. Infect. Dis. 189, 360–368.

    Article  CAS  PubMed  Google Scholar 

  21. Binnington, B., Lingwood, D., Nutikka, A., and Lingwood, C. (2002) Effect of globotriaosyl ceramide fatty acid hydroxylation on the binding by Verotoxin 1 and Verotoxin 2. Neurochem. Res. 27, 807–813.

    Article  CAS  PubMed  Google Scholar 

  22. Ling, H., Boodhoo, A., Hazes, B., et al. (1998) Structure of the Shiga toxin B-pentamer complexed with an analogue of its receptor Gb3. Biochem. 37, 1777–1788.

    Article  CAS  Google Scholar 

  23. Thompson, G., Shimizu, H., Homans, S., and Donohue-Rolfe, A. (2000) Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements. Biochem. 39, 13,153–13,156.

    Article  CAS  Google Scholar 

  24. Soltyk, A. M., MacKenzie, C. R., Wolski, V. M., et al. (2002) A mutational analysis of the Globotriaosylceramide binding sites of Verotoxin VT1. J. Biol. Chem. 277, 5351–5359.

    Article  CAS  PubMed  Google Scholar 

  25. Mylvaganam, M. and Lingwood, C. (1999) AdaGb3—a monovalent soluble glycolipid mimic which inhibits verotoxin binding to its glycolipid receptor. Biochem. Biophys. Res. Comm. 257, 391–394.

    Article  CAS  PubMed  Google Scholar 

  26. Whetstone, D. and Lingwood, C. (2003) 3′Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro. Biochem. 42, 1611–1617.

    Article  CAS  Google Scholar 

  27. Chandler, D. (2002) The two faces of water. Nature 417, 491.

    Article  CAS  PubMed  Google Scholar 

  28. Lund, N., Branch, D. R., Mylvaganam, D., et al. (2006) A novel soluble mimic of the glycolipid globotriaosyl ceramide inhibits HIV infection. AIDS 20, 1–11.

    Article  Google Scholar 

  29. Pellizzari, A., Pang, H., and Lingwood, C. A. (1992) Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochem. 31, 1363–1370.

    Article  CAS  Google Scholar 

  30. Lingwood, C. A., Murray, R. K., and Schachter, H. (1980) The preparation of rabbit antiserum specific for mammalian testicular sulfogalactoglycerolipid. J. Immunol. 124, 769–774.

    CAS  PubMed  Google Scholar 

  31. Koshy, K. and Boggs, J. (1983) Partial synthesis and physical properties of cerebroside sulfate containing palmitic acid or alpha-hydroxy palmitic acid. Chem. Phys. Lip. 34, 41–53.

    Article  CAS  Google Scholar 

  32. Mahfoud, R., Mylvaganam, M., Lingwood, C. A., and Fantini, J. (2002) A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide(Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction. J. Lipid Res. 43, 1670–1679.

    Article  CAS  PubMed  Google Scholar 

  33. Puri, A., Hug, P., Jernigan, K., Rose, P., and Blumenthal, R. (1999) Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion. Biosci. Rep. 19, 317–325.

    Article  CAS  PubMed  Google Scholar 

  34. Puri, A., Hug, P., Jernigan, K., et al. (1998) The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1_envelope glycoprotein. Proc. Natl. Acad. Sci. USA 95, 14,435–14,440.

    Article  CAS  PubMed  Google Scholar 

  35. Hammache, D., Yahi, N., Maresca, M., Pieroni, G., and Fantini, J. (1999) Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J. Virol. 73, 5244–5248.

    CAS  PubMed  Google Scholar 

  36. Delezay, O., Hammache, D., Fantini, J., and Yahi, N. (1996) SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry 35, 15,663–15,671.

    Article  CAS  PubMed  Google Scholar 

  37. Mylvaganam, M. and Lingwood, C. A. (1999) A convenient oxidation of natural glycosphingolipids to their “ceramide acids” for neoglycoconjugation: Bovine serum albumin-glycoceramide acid conjugates as investigative probes for HIV coat protein gp120-glycosphingolipid interactions. J. Biol. Chem. 274, 20,725–20,732.

    Article  CAS  PubMed  Google Scholar 

  38. Peter, M. and Lingwood, C. (2000) Apparent cooperativity in multivalent verotoxin globotriaosyl ceramide binding: Kinetic and saturation binding experiments with radiolabelled verotoxin [125I]-VT1. Biochim. Biophys. Acta 1501, 116–124.

    CAS  PubMed  Google Scholar 

  39. Rutjes, N., Binnington, B., Smith, C., Maloney, M., and Lingwood, C. (2002) Differential tissue targeting and pathogenesis of Verotoxins 1 and 2 in the mouse animal model. Kid. Intl. 62, 832–845.

    Article  CAS  Google Scholar 

  40. Chark, D., Nutikka, A., Trusevych, N., Kuzmina, J., and Lingwood, C. (2004) Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and monoclonal antibody: Role in human renal glomerular binding. Eur. J. Biochem. 271, 1–13.

    Article  Google Scholar 

  41. Khine, A. A., Tam, P., Nutikka, A., and Lingwood, C. A. (2004) Brefeldin A and filipin distinguish two Globotriaosyl ceramide/Verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 14, 701–712.

    Article  CAS  PubMed  Google Scholar 

  42. Boulanger, J., Faulds, D., Eddy, E. M., and Lingwood, C. A. (1995) Members of the 70kDa heat shock protein family specifically recognize sulfoglycolipids: role in gamete recognition and mycoplasma related infertility. J. Cell. Physiol. 165, 7–17.

    Article  CAS  PubMed  Google Scholar 

  43. Mamelak, D., Mylvaganam, M., Whetstone, H., et al. (2001) Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by prokaryotic and eukaryotic hsp70 family members. Biochemistry 40, 3572–3582.

    Article  CAS  PubMed  Google Scholar 

  44. Mamelak, D. and Lingwood, C. (2001) The ATPase domain of Hsp70 possesses a unique binding specificity for 3′sulfogalactolipids. J. Biol. Chem. 276, 449–456.

    Article  CAS  PubMed  Google Scholar 

  45. Sondermann, H., Scheufler, C., Schneider, C., Höfeld, J., Hartl, F.-U., and Moarefi, I. (2001) Structure of a Bag/Hsc70 complex: convergent functional evolution of Hsp70 nucleotide exchange factors. Science 291, 1553–1557.

    Article  CAS  PubMed  Google Scholar 

  46. Huesca, M., Goodwin, A., Bhagwansingh, A., Hoffman, P., and Lingwood, C. A. (1998) Characterization of a stress protein (hsp70) induced by acidic pH, a putative sulfatide binding adhesin, from Helicobacter pylori. Infect. Immun. 66, 4061–4067.

    CAS  PubMed  Google Scholar 

  47. Hartmann, E. and Lingwood, C. A. (1997) Brief heat shock induces a long-lasting alteration in the glycolipid receptor binding specificity of Hemophilus influenzae. Infect. Immun. 65, 1729–1733.

    CAS  PubMed  Google Scholar 

  48. Skehel, J. J. and Wiley, D. C. (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Ann. Rev. Biochem. 69, 531–569.

    Article  CAS  PubMed  Google Scholar 

  49. Suzuki, T., Sometani, A., Yamazaki, Y., et al. (1996) Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem. J. 318, 389–393.

    CAS  PubMed  Google Scholar 

  50. Huesca, M., Borgia, S., Hoffman, P., and Lingwood, C. A. (1996) Acidic pH changes receptor binding of Helicobacter pylori: a binary adhesion model in which surface heat-shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect. Immun. 64, 2643–2648.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this protocol

Cite this protocol

Lingwood, C., Sadacharan, S., Abul-Milh, M., Mylvaganum, M., Peter, M. (2006). Soluble Adamantyl Glycosphingolipid Analogs as Probes of Glycosphingolipid Function. In: Brockhausen, I. (eds) Glycobiology Protocols. Methods in Molecular Biology, vol 347. Humana Press. https://doi.org/10.1385/1-59745-167-3:305

Download citation

  • DOI: https://doi.org/10.1385/1-59745-167-3:305

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-553-8

  • Online ISBN: 978-1-59745-167-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics